361 related articles for article (PubMed ID: 32849279)
1. The Other Obesity Epidemic-Of Drugs and Bugs.
Sfera A; Osorio C; Diaz EL; Maguire G; Cummings M
Front Endocrinol (Lausanne); 2020; 11():488. PubMed ID: 32849279
[TBL] [Abstract][Full Text] [Related]
2. Nutritional and therapeutic approaches for protecting human gut microbiota from psychotropic treatments.
Ait Chait Y; Mottawea W; Tompkins TA; Hammami R
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110182. PubMed ID: 33232785
[TBL] [Abstract][Full Text] [Related]
3. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
Amabebe E; Robert FO; Agbalalah T; Orubu ESF
Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota Dysbiosis in Human Obesity: Impact of Bariatric Surgery.
Debédat J; Clément K; Aron-Wisnewsky J
Curr Obes Rep; 2019 Sep; 8(3):229-242. PubMed ID: 31197613
[TBL] [Abstract][Full Text] [Related]
5. [Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].
Ruetsch O; Viala A; Bardou H; Martin P; Vacheron MN
Encephale; 2005; 31(4 Pt 1):507-16. PubMed ID: 16389718
[TBL] [Abstract][Full Text] [Related]
6. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
7. Obesity and psychotropics.
Nihalani N; Schwartz TL; Siddiqui UA; Megna JL
CNS Neurosci Ther; 2012 Jan; 18(1):57-63. PubMed ID: 22070396
[TBL] [Abstract][Full Text] [Related]
8. Tributyltin exposure induces gut microbiome dysbiosis with increased body weight gain and dyslipidemia in mice.
Guo H; Yan H; Cheng D; Wei X; Kou R; Si J
Environ Toxicol Pharmacol; 2018 Jun; 60():202-208. PubMed ID: 29738946
[TBL] [Abstract][Full Text] [Related]
9. The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?
Magne F; Gotteland M; Gauthier L; Zazueta A; Pesoa S; Navarrete P; Balamurugan R
Nutrients; 2020 May; 12(5):. PubMed ID: 32438689
[TBL] [Abstract][Full Text] [Related]
10. The Role of the Gut Microbiota in the Gut-Brain Axis in Obesity: Mechanisms and Future Implications.
van Son J; Koekkoek LL; La Fleur SE; Serlie MJ; Nieuwdorp M
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804250
[TBL] [Abstract][Full Text] [Related]
11. Neohesperidin attenuates obesity by altering the composition of the gut microbiota in high-fat diet-fed mice.
Lu JF; Zhu MQ; Zhang H; Liu H; Xia B; Wang YL; Shi X; Peng L; Wu JW
FASEB J; 2020 Sep; 34(9):12053-12071. PubMed ID: 32729978
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
Lee P; Yacyshyn BR; Yacyshyn MB
Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet.
Kang C; Wang B; Kaliannan K; Wang X; Lang H; Hui S; Huang L; Zhang Y; Zhou M; Chen M; Mi M
mBio; 2017 May; 8(3):. PubMed ID: 28536285
[TBL] [Abstract][Full Text] [Related]
14. Psychiatric medication-induced obesity: a review.
Schwartz TL; Nihalani N; Jindal S; Virk S; Jones N
Obes Rev; 2004 May; 5(2):115-21. PubMed ID: 15086865
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota mediates the protective effects of dietary β-hydroxy-β-methylbutyrate (HMB) against obesity induced by high-fat diets.
Duan Y; Zhong Y; Xiao H; Zheng C; Song B; Wang W; Guo Q; Li Y; Han H; Gao J; Xu K; Li T; Yin Y; Li F; Yin J; Kong X
FASEB J; 2019 Sep; 33(9):10019-10033. PubMed ID: 31167080
[TBL] [Abstract][Full Text] [Related]
17. Obesity, Motility, Diet, and Intestinal Microbiota-Connecting the Dots.
Fayfman M; Flint K; Srinivasan S
Curr Gastroenterol Rep; 2019 Mar; 21(4):15. PubMed ID: 30887257
[TBL] [Abstract][Full Text] [Related]
18. Microbiota and Obesity.
Isolauri E
Nestle Nutr Inst Workshop Ser; 2017; 88():95-105. PubMed ID: 28346926
[TBL] [Abstract][Full Text] [Related]
19. Microbial balance in the intestinal microbiota and its association with diabetes, obesity and allergic disease.
Gholizadeh P; Mahallei M; Pormohammad A; Varshochi M; Ganbarov K; Zeinalzadeh E; Yousefi B; Bastami M; Tanomand A; Mahmood SS; Yousefi M; Asgharzadeh M; Kafil HS
Microb Pathog; 2019 Feb; 127():48-55. PubMed ID: 30503960
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.
Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
